DEF14A

Company

IRONWOOD PHARMACEUTICALS INC

Filed

April 25, 2024

Period of Report

June 18, 2024

Accession Number

0001104659-24-051992

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →